亚太地区肌肉减少症治疗市场预测至 2030 年 - 区域分析 - 按治疗类型（维生素 D 和钙补充剂、蛋白质补充剂、维生素 B12 补充剂等）和分销渠道（药店、零售渠道、在线渠道等）
临床试验阶段的产品推动亚太地区肌肉减少症治疗市场的发展
肌肉减少症治疗市场中的几家主要参与者越来越关注治疗肌肉减少症的药物开发。新型肌肉减少症治疗方法目前正在开发和临床试验中测试。下面列出了其中一些产品：
表 1. 临床开发中的肌肉减少症药物
公司名称干预条件临床试验阶段
雅培营养含有 AN777 的医疗食品
口服营养配方营养不良
肌肉减少症 PHASE3
Nutricia Research 膳食补充剂：Bolus ONS A
膳食补充剂：Bolus ONS B
膳食补充剂：Bolus ONS C
膳食补充剂：Bolus ONS D 肌肉减少症 PHASE1
诺华制药药物：Bimagrumab 肌肉减少症 PHASE2
麦克马斯特大学行为：逐步减少肌肉减少症 PHASE1
代谢技术公司膳食补充剂：安慰剂
药物：HMB Plus 维生素 D
行为：非运动
行为：运动性肌肉减少症 PHASE1
Merck Sharp & Dohme LLC 药物：比较剂 MK-077
药物：比较剂安慰剂肌肉减少症 PHASE2
Immunotec Inc. 膳食补充剂：Immunocal
膳食补充剂：酪蛋白老化和肌肉减少症 PHASE2
Lijun Yang 组合产品：3 个月强化干预肌肉减少症 PHASE4
Regeneron Pharmaceuticals 药物：REGN1033 (SAR391786)
药物：安慰剂肌肉减少症 PHASE2
来源：公司网站和 Insight Partners 分析
因此，处于不同临床开发阶段的药物管线的扩展为肌肉减少症的治疗提供了重大机遇治疗市场增长。
亚太地区肌肉减少症治疗市场概览
亚太地区肌肉减少症治疗市场分为中国、印度、日本、韩国、澳大利亚和亚太地区其他地区。预计在预测期内，亚太地区将在全球市场上实现最快的复合年增长率。亚洲是世界上人口最多的大陆，人口老龄化迅速，与肌肉减少症相关的问题在几个亚洲国家变得越来越普遍。亚洲人的生活方式和饮食习惯与西方人截然不同。在亚洲，老年人的肌肉减少症在男性（患病率为 9.6-22.1%）中比女性（患病率为 7.7-21.8%）中更为常见。亚洲肌肉减少症工作组 (AWGS) 旨在促进亚洲的肌肉减少症研究。
亚太地区肌肉减少症治疗市场收入及预测至 2030 年（百万美元）
亚太地区肌肉减少症治疗市场细分
亚太地区肌肉减少症治疗市场分为治疗类型、分销渠道和国家/地区。
根据治疗类型，亚太地区肌肉减少症治疗市场细分为维生素 D 和钙补充剂、蛋白质补充剂、维生素 B12 补充剂等。维生素 D 和钙补充剂部分在 2022 年占据了亚太地区肌肉减少症治疗市场的最大份额。
在分销渠道方面，亚太地区肌肉减少症治疗市场细分为药店、零售渠道、在线渠道和其他。药店部分在 2022 年占据了亚太地区肌肉减少症治疗市场的最大份额。
按国家/地区划分，亚太地区肌肉减少症治疗市场细分为中国、印度、日本、澳大利亚、韩国和亚太地区其他地区。 2022 年，中国占据了亚太地区肌肉减少症治疗市场的主导份额。
雅培实验室、拜耳公司、Metagenics LLC、雀巢健康科学公司、诺华公司、辉瑞公司、赛诺菲公司、安利公司和葛兰素史克公司是亚太地区肌肉减少症治疗市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Asia Pacific Market Analysis
5.1 Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 Asia Pacific Sarcopenia Treatment Market Forecast and Analysis
6. Asia Pacific Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Sarcopenia Treatment Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.7 Rest of Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.7.1 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.7.2 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Metagenics LLC
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Nestle Health Science SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Novartis AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Pfizer Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Sanofi SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Amway Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 GSK Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 14. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 15. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 16. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 17. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 18. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 21. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. Asia Pacific Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. Asia Pacific Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Asia Pacific Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Asia Pacific Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Asia Pacific Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 20. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 21. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 22. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Metagenics LLC
4. Nestle Health Science SA
5. Novartis AG
6. Pfizer Inc
7. Sanofi SA
8. Amway Corp
9. GSK Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.